Metabolite Changes in Normal-Appearing Gray and White Matter Are Linked With Disability in Early Primary Progressive Multiple Sclerosis

Authors:

Abstract
Changes in normal-appearing white matter (NAWM) in multiple sclerosis (MS) have been demonstrated early in the clinical course of the disease by a range of magnetic resonance (MR) techniques and are clinically relevant.1 The most pathologically specific of these techniques, proton MR spectroscopy (MRS), which estimates the concentration of a number of metabolites in vivo, has shown reduced N-acetyl-aspartate, a putative marker of axonal loss or dysfunction, in the NAWM of patients with MS.2 The use of short-echo MRS imaging (MRSI) together with more sophisticated quantification techniques3 makes it possible to determine the levels of other metabolites, such as myo-inositol and glutamate-glutamine, which could reflect other pathological processes, such as astrogliosis.

This publication has 17 references indexed in Scilit: